Syndex Bio
Biotechnology company specializing in the development of genomics-based tools for biological discovery, integrating molecular technologies and instrumentation to enable novel drug discovery approaches.
Website
https://www.syndexbio.comLocation
San Francisco, California, USA
Founded
2022
Investors
1
Categories
genomics, drug-discovery, biotech, platform, instrumentation
Notes
Syndex Bio is a biotechnology company founded in 2022, specializing in the development of genomics-based tools for biological discovery. The company integrates molecular technologies and instrumentation to enable novel approaches to drug discovery and biological research.
The company's platform combines advances in genomics, molecular biology, and instrumentation to provide researchers with new tools for understanding biological systems and discovering new therapeutic targets.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Genomics-based tools platform
- Drug discovery applications
- Molecular technologies integration
- Instrumentation development
- San Francisco, California headquarters
- Founded in 2022
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| OMX Ventures | San Francisco, California, USA | biotech-focused | seedseries-a | 23 |